ALNY - Alnylam Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 59.42B
Enterprise Value 38.53B
Trailing P/E N/A
Forward P/E 1-12.73
PEG Ratio (5 yr expected) 1-0.23
Price/Sales (ttm)125.78
Price/Book (mrq)6.89
Enterprise Value/Revenue 3113.93
Enterprise Value/EBITDA 6-10.56

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Dec 31, 2018


Profit Margin 0.00%
Operating Margin (ttm)-1,087.56%

Management Effectiveness

Return on Assets (ttm)-28.53%
Return on Equity (ttm)-49.63%

Income Statement

Revenue (ttm)74.91M
Revenue Per Share (ttm)0.75
Quarterly Revenue Growth (yoy)-44.50%
Gross Profit (ttm)73.11M
EBITDA -808.24M
Net Income Avi to Common (ttm)-761.5M
Diluted EPS (ttm)-7.57
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.08B
Total Cash Per Share (mrq)10.2
Total Debt (mrq)30M
Total Debt/Equity (mrq)2.30
Current Ratio (mrq)6.69
Book Value Per Share (mrq)12.87

Cash Flow Statement

Operating Cash Flow (ttm)-562.62M
Levered Free Cash Flow (ttm)-475.89M

Trading Information

Stock Price History

Beta (3Y Monthly) 2.30
52-Week Change 3-38.30%
S&P500 52-Week Change 34.46%
52 Week High 3149.73
52 Week Low 360.27
50-Day Moving Average 383.84
200-Day Moving Average 382.37

Share Statistics

Avg Vol (3 month) 3859.07k
Avg Vol (10 day) 3647.67k
Shares Outstanding 5106.3M
Float 94.8M
% Held by Insiders 110.80%
% Held by Institutions 188.39%
Shares Short (Feb 28, 2019) 45.19M
Short Ratio (Feb 28, 2019) 46.74
Short % of Float (Feb 28, 2019) 410.94%
Short % of Shares Outstanding (Feb 28, 2019) 44.88%
Shares Short (prior month Jan 31, 2019) 45.75M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A